BrainChild Bio Closes $116 Million Series A Financing

Post navigation

← Tech Moves: WRF announces new cohort of Venture Analysts BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer →

Comments are closed.

Home
Contact
LinkedIn

About Us

Grants

Startup Investments
- Investing in Washington
- Active Portfolio & Exits

News
- Articles
- Stories
- Videos

Washington Research Foundation is committed to supporting and welcoming a broad pool of researchers, board members and staff who represent a range of perspectives. We encourage people from all communities to apply for our employment, grantmaking and investment opportunities.

Terms of Use
Privacy Policy
(206) 336-5600
Site by The Medium

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
- Stories
- Videos
News
- Articles
- Reports
Contact